However, the company announced mid-last-week that while the special virtual-only meeting of shareholders where a majority voted in favor of the company’s domestication to Delaware, shareholders failed to complete a 2/3 vote in favor of it, and the localization will therefore not happen.
Covered by approximately 70 granted and pending patents, the TRUFORMA diagnostic platform uses Qorvo’s (NASDAQ: QRVO) developed Bulk Acoustic Wave technology to provide a non-optical and fluorescence-free point-of-care detection method. This technology is widely used in the most advanced radar and communication systems globally and has proven extremely reliable and precise. Sales of TRUFORMA are expected to begin on March 30, 2021, according to Zomedica.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Read More
